Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed at $7.96 in the last session, up 3.18% from day before closing price of $7.72. In other words, the price has increased by $3.18 from its previous closing price. On the day, 0.93 million shares were traded. AMLX stock price reached its highest trading level at $8.12 during the session, while it also had its lowest trading level at $7.56.
Ratios:
We take a closer look at AMLX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.05 and its Current Ratio is at 12.05. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On June 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $17.
On June 17, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $12.Citigroup initiated its Buy rating on June 17, 2025, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 31 ’25 when FRATES JAMES M sold 10,896 shares for $3.47 per share. The transaction valued at 37,806 led to the insider holds 290,988 shares of the business.
Bedrosian Camille L sold 12,425 shares of AMLX for $43,082 on Mar 31 ’25. The Chief Medical Officer now owns 194,375 shares after completing the transaction at $3.47 per share. On Mar 31 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 9,192 shares for $3.48 each. As a result, the insider received 31,954 and left with 187,969 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 709563200 and an Enterprise Value of 506877056. Its current Enterprise Value per Revenue stands at -398.488 whereas that against EBITDA is -2.451.
Stock Price History:
The Beta on a monthly basis for AMLX is -0.43, which has changed by 3.0406094 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, AMLX has reached a high of $8.72, while it has fallen to a 52-week low of $1.76. The 50-Day Moving Average of the stock is 21.82%, while the 200-Day Moving Average is calculated to be 64.26%.
Shares Statistics:
According to the various share statistics, AMLX traded on average about 1.47M shares per day over the past 3-months and 1113980 shares per day over the past 10 days. A total of 89.08M shares are outstanding, with a floating share count of 66.23M. Insiders hold about 25.70% of the company’s shares, while institutions hold 79.16% stake in the company. Shares short for AMLX as of 1752537600 were 7466420 with a Short Ratio of 5.07, compared to 1749772800 on 4039910. Therefore, it implies a Short% of Shares Outstanding of 7466420 and a Short% of Float of 9.24.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
